Explore All Access
Check if your research matches the topics covered in Melanoma Research?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Melanoma Research : Impact Factor & More
eISSN: 1473-5636pISSN: 0960-8931
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Aims and Scope
Melanoma Research (print: ISSN 0960-8931, online: ISSN 1473-5636) is a peer-reviewed medical journal published by Lippincott Williams & Wilkins since 1991. The journal publishes current findings on melanoma. Articles include both experimental and clinical research in a broad range of related subjects, including genetics, molecular biology, biochemistry, cell biology, photobiology, pathology, and immunology, and advances in clinical oncology influencing the prevention, diagnosis, and treatment of melanoma. Melanoma Research is published bimonthly. The current editor-in-chief is F.J. Lejeune. Less
Melanoma Research Key Metrics
CiteScore 
6.7
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.88
Topics Covered on Melanoma Research
Immunotherapy
Lymph node
Melanoma
Copy number gain
Progression-free survival
Vemurafenib
MEK inhibitor
Overall survival
Dabrafenib
Clinicopathological features
Cutaneous melanoma
Confidence interval
Surgical resection
Hemophagocytic lymphohistiocytosis
Advanced melanoma
Sentinel lymph node
Toxicity
Polymyositis
Cell cycle
Complete response
Melanoma Research Journal Specifications
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Melanoma Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Melanoma Research
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study.
- 3 Dec 2024
- Melanoma research
Melanoma in the head and neck region: the value of preoperative imaging in melanoma stage I-II.
- 3 Dec 2024
- Melanoma research
ATF3 regulates CDC42 transcription and influences cytoskeleton remodeling, thus inhibiting the proliferation, migration and invasion of malignant skin melanoma cells.
- 26 Nov 2024
- Melanoma research
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.
- 11 Nov 2024
- Melanoma research
Development and validation of prognostic nomogram in pediatric melanoma: a population-based study.
- 30 Oct 2024
- Melanoma research
The association between dermatologist density and melanoma prognosis using melanoma mortality-incidence ratio.
- 30 Oct 2024
- Melanoma research
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study.
- 3 Dec 2024
- Melanoma research
Melanoma in the head and neck region: the value of preoperative imaging in melanoma stage I-II.
- 3 Dec 2024
- Melanoma research
ATF3 regulates CDC42 transcription and influences cytoskeleton remodeling, thus inhibiting the proliferation, migration and invasion of malignant skin melanoma cells.
- 26 Nov 2024
- Melanoma research
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.
- 11 Nov 2024
- Melanoma research
Development and validation of prognostic nomogram in pediatric melanoma: a population-based study.
- 30 Oct 2024
- Melanoma research
The association between dermatologist density and melanoma prognosis using melanoma mortality-incidence ratio.
- 30 Oct 2024
- Melanoma research
Compare Similar Journals with Melanoma Research
Select Journals to Compare with Melanoma Research
Total journals - 10
You can select up to 3 Journals at a time
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Oncology
Publisher: ELSEVIER
Cancers
Publisher: MDPI
Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
European Journal of Cancer
Publisher: ELSEVIER SCI LTD
Journal for ImmunoTherapy of Cancer
Publisher: BMJ PUBLISHING GROUP
Clinical Cancer Research
Publisher: AMER ASSOC CANCER RESEARCH
Oncotarget
Publisher: Impact Journals
BMC Cancer
Publisher: BMC
0 Journals Selected to compare with
Melanoma Research
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Melanoma Research
How long has Melanoma Research been actively publishing? 
Melanoma Research has been in operation since 1991 till date.
What is the publishing frequency of Melanoma Research?
Melanoma Research published with a Bi-monthly frequency.
How many articles did Melanoma Research publish last year?
In 2023, Melanoma Research publsihed 78 articles.
What is the eISSN & pISSN for Melanoma Research?
For Melanoma Research, eISSN is 1473-5636 and pISSN is 0960-8931.
What is Citescore for Melanoma Research?
Citescore for Melanoma Research is 6.7.
What is SNIP score for Melanoma Research?
SNIP score for Melanoma Research is 0.88.
What is the SJR for Melanoma Research?
SJR for Melanoma Research is Q2.
Who is the publisher of Melanoma Research?
LIPPINCOTT WILLIAMS & WILKINS is the publisher of Melanoma Research.
